ROXARIVABEN 15 Mg: Uses, Dosage, Side Effects, Price, Composition and More...

ROXARIVABEN 15:

Rivaroxaban 15mg,

ROXARIVABEN 15, featuring Rivaroxaban 15mg, is a premier anticoagulant medication tailored for patients requiring a stronger dose for the treatment and prevention of thromboembolic disorders. It offers precise, targeted action to mitigate the risk of blood clots in conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE).

What is ROXARIVABEN 15?

ROXARIVABEN 15 is an oral anticoagulant that stands out for its efficacy in controlling and preventing blood clots. As part of the direct factor Xa inhibitors class, it plays a crucial role in the blood coagulation process, providing reliable protection against the formation of dangerous clots.

Effective Mechanism of ROXARIVABEN 15

• Selective Factor Xa Inhibition: By directly inhibiting factor Xa, ROXARIVABEN 15 prevents the conversion of prothrombin to thrombin, a key step in the blood clotting process. This action reduces the formation of clots without the need for routine blood monitoring.

Key Advantages of ROXARIVABEN 15

• Targeted Clot Prevention and Treatment: ROXARIVABEN 15 is effective in treating existing blood clots and preventing the formation of new clots, particularly in patients with DVT or PE.
• Convenient Dosage Regimen: The 15mg strength allows for a more tailored treatment approach, catering to patients who need a moderate intensity of anticoagulation.
• Lower Bleeding Risk: Compared to traditional anticoagulants, ROXARIVABEN 15 offers a balance between effective anticoagulation and a reduced risk of bleeding, enhancing patient safety.

Who Should Use ROXARIVABEN 15?

ROXARIVABEN 15 is ideal for individuals diagnosed with DVT or PE who require immediate and effective anticoagulation. It is also suitable for patients transitioning from initial anticoagulation therapy to long-term management.

Recommended Usage

It is important to use ROXARIVABEN 15 under the supervision of a healthcare professional. The usual dose is 15mg twice daily for the first three weeks for the treatment of DVT or PE, followed by a maintenance dose based on the clinical evaluation.

In Summary

ROXARIVABEN 15 represents a significant advance in the field of anticoagulation therapy, providing patients with an effective and safe option for the treatment and prevention of blood clots. With its focused mechanism of action and patient-centered benefits, ROXARIVABEN 15 is a key player in the management of thromboembolic disorders.

For those in need of effective clot management, consulting a healthcare provider about ROXARIVABEN 15 can be a vital step in securing optimal vascular health and preventing the complications associated with blood clots.

A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   BUY NOW